- Salinomycin
-
- $5.00/ KG
-
2026-02-06
- CAS:53003-10-4
- Min. Order: 1KG
- Purity: 99% hplc
- Supply Ability: 500TONS
- Salinomycin
-
-
2026-02-06
- CAS:53003-10-4
- Min. Order:
- Purity: 0.99
- Supply Ability:
- Salinomycin
-
- $32.00 / 1mg
-
2026-01-30
- CAS:53003-10-4
- Min. Order:
- Purity: 97.48%
- Supply Ability: 10g
|
| | Salinomycin Basic information |
| Product Name: | Salinomycin | | Synonyms: | SALINOMYCIN SODIUM;coxistac;SALINOMYCIN GRANULE;Salinomycin Premix 12%;SALINOMYCIN FROM STREPTOMYCES ALBUS;SALINOMYCIN 90%;SV sodium salt,2,5 salinomycin hydrate;(2R)-2-((5S)-6-{5-[(10S,12R)-2-((6S,5R)-5-Ethyl-5-hydroxy-6-methylperhydro-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl](1S,2S,3S,5R)-2-hydroxy-1,3-dimethyl-4-oxoheptyl}-5-methylperhydro-2H-pyran-2-yl)butanoic acid | | CAS: | 53003-10-4 | | MF: | C42H70O11 | | MW: | 751 | | EINECS: | 258-290-1 | | Product Categories: | KOKCISAN;Antibacterial;Antibiotics;Antibiotics A to;Antibiotics N-SAntibiotics;Chemical Structure Class;L - ZAntibiotics;Mechanism of Action;Monovalent Ion Channels;Polyethers;Inhibitors;Interferes with Cell Membrane Permeability (Ionophores)Voltage-gated Ion Channels;IonophoresSpectrum of Activity;53003-10-4 | | Mol File: | 53003-10-4.mol |  |
| | Salinomycin Chemical Properties |
| Melting point | 112.5-113.5 °C(lit.) | | alpha | D25 -63° (c = 1 in ethanol) | | Boiling point | 839.2±65.0 °C(Predicted) | | density | 1.18±0.1 g/cm3(Predicted) | | Fp | >110°(230°F) | | storage temp. | Sealed in dry,2-8°C | | solubility | insoluble in H2O; ≥142.2 mg/mL in EtOH; ≥91.8 mg/mL in DMSO | | form | White solid | | pka | 6.4 (DMF) | | color | White to light yellow | | Optical Rotation | -6325 (cl, ethanol) | | biological source | Streptomyces albus | | Water Solubility | Soluble in methanol. Insoluble in water | | Merck | 13,8415 | | Stability: | Stable, but may be heat sensitive - keep cool. Incompatible with strong oxidizing agents. | | InChIKey | KQXDHUJYNAXLNZ-XQSDOZFQSA-N | | LogP | 5.596 (est) | | CAS DataBase Reference | 53003-10-4(CAS DataBase Reference) |
| Hazard Codes | T,Xi | | Risk Statements | 25-36/37/38 | | Safety Statements | 45-36-26 | | RIDADR | UN 3462 6.1/PG 2 | | WGK Germany | 3 | | RTECS | VO8620000 | | F | 10 | | HazardClass | 6.1(a) | | PackingGroup | II | | Storage Class | 6.1A - Combustible acute toxic Cat. 1 and 2
very toxic hazardous materials | | Hazard Classifications | Acute Tox. 2 Oral | | Hazardous Substances Data | 53003-10-4(Hazardous Substances Data) | | Toxicity | LD50 in mice (mg/kg): 18 i.p.; 50 orally (Miyazaki) |
| Provider | Language |
|
(2R)-2-((5S)-6-{5-[(10S,12R)-2-((6S,5R)-5-Ethyl-5-hydroxy-6-methylperhydro-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl](1S,2S,3S,5R)-2-hydroxy-1,3-dimethyl-4-oxoheptyl}-5-methylperhydro-2H-pyran-2-yl)butanoic acid
| English |
|
SigmaAldrich
| English |
| | Salinomycin Usage And Synthesis |
| Description | Salinomycin was found in the culture mycelium of Streptomyces albus by Otake et al. of the University of Tokyo in 1973. Like other polyether ionophore antibiotics, it shows activity against gram-positive bacteria, fungi, and Coccidium. Salinomycin has been used as a feed additive to protect poultry against coccidial infections. | | Chemical Properties | solid | | Uses | antibacterial | | Uses | Salinomycin is a polyether ionophore with broad spectrum Gram positive and anti-coccidial activity. Salinomycin has a high affinity for monovalent cations, particularly potassium. Salinomycin is used to control coccidia in animals and for growth promotion in ruminants. Recently, salinomycin has been shown to inhibit cancer stem cells and is >100 times more potent than taxol. While the mechanism of action is unknown, it was noted that among the 60,000 compounds screened, another monovalent ionophore, nigericin, and a chloride channel inhibitor, avermectin, were also active. | | Uses | Salinomycin was used as a standard in the development of LC-MS/MS method for detection of residual coccidiostats in egg and muscle samples. It was used to screen out CD44+CD24- mesenchymal-like subpopulation within breast carcinomas. | | Definition | ChEBI: Salinomycin is a polyketide and a spiroketal. It has a role as an animal growth promotant and a potassium ionophore. | | General Description | Chemical structure: polyether | | Biological Activity | salinomycin (sal), which is a polyether ionophore antibiotic from streptomyces albus, has been proven to be able to kill different types of human cancer cells, most likely via interfering with abc drug transporters, the wnt/β-catenin signaling pathway, or other pathways. | | Biochem/physiol Actions | Salinomycin produced by Streptomyces albus is a carboxylic polyether ionophore with antibiotic and anti-cancer properties. It induces cell death in some types of cancer cells such as breast, lung, gastric cancer, leukemia and osteosarcoma. Salinomycin inhibits multidrug resistance protein 1 and induces apoptosis by the generation of reactive oxygen species that cause DNA damage and inactivation of Stat3. Use of salinomycin as antibiotic results in lowered spermatozoa count and motility and decreased steroidogenesis in mice. | | in vitro | several hepatocellular carcinoma (hcc) cell lines were treated with sal. results showed that sal inhibited proliferation and decreased pcna levels. cell cycle analysis showed that sal caused cell cycle arrest in different phases. sal induced apoptosis as characterized by an increase in the bax/bcl-2 ratio. compared to control, β-catenin expression was down-regulated by sal treatment significantly. the ca2+ concentration in hcc cells was examined by flow cytometry and it was found that higher ca2+ concentrations were observed in sal treatment groups [1]. | | in vivo | the in vivo anti-tumor effect of sal was verified using the hepatoma orthotopic tumor model and results showed that the liver tumor size in sal-treated groups decreased. immunohistochemistry and tunel staining also demonstrated that sal could in vivo inhibit proliferation and induced apoptosis [1]. | | IC 50 | 7.7, 13.7 and 10.4 μm for hepg2, smmc-7721 and bel-7402 cell line, respectively (after 24h treatment) | | References | [1] JOHANNES KLOSE. Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.[J]. PLoS ONE, 2019: e0211916. DOI:10.1371/journal.pone.0211916.
[2] DESHENG LU. Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2011: 13253-13257. DOI:10.1073/pnas.1110431108.
[3] LONGQIN WANG . Self-assembly driven nano-salinomycin for high-efficiency cancer immunotherapy by reticulum stress mediated stemness suppression[J]. Biomaterials, 2025, 325: Article 123632. DOI:10.1016/j.biomaterials.2025.123632.
[4] FAN WANG. Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.[J]. PLoS ONE, 2012: e50638. DOI:10.1371/journal.pone.0050638. |
| | Salinomycin Preparation Products And Raw materials |
|